3-186080012-G-T

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBS2_Supporting

The NM_004454.3(ETV5):​c.455C>A​(p.Pro152Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000722 in 1,550,264 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000073 ( 0 hom. )

Consequence

ETV5
NM_004454.3 missense

Scores

1
5
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.04
Variant links:
Genes affected
ETV5 (HGNC:3494): (ETS variant transcription factor 5) Enables DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in cellular response to oxidative stress; negative regulation of transcription by RNA polymerase II; and positive regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
ETV5-AS1 (HGNC:40222): (ETV5 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.21762297).
BS2
High AC in GnomAd4 at 10 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ETV5NM_004454.3 linkuse as main transcriptc.455C>A p.Pro152Gln missense_variant 7/13 ENST00000306376.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ETV5ENST00000306376.10 linkuse as main transcriptc.455C>A p.Pro152Gln missense_variant 7/131 NM_004454.3 P1P41161-1
ETV5-AS1ENST00000453370.1 linkuse as main transcriptn.173-548G>T intron_variant, non_coding_transcript_variant 4

Frequencies

GnomAD3 genomes
AF:
0.0000658
AC:
10
AN:
152060
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000994
AC:
19
AN:
191180
Hom.:
0
AF XY:
0.000123
AC XY:
13
AN XY:
105566
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000105
Gnomad ASJ exome
AF:
0.000133
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000492
Gnomad NFE exome
AF:
0.000151
Gnomad OTH exome
AF:
0.000230
GnomAD4 exome
AF:
0.0000730
AC:
102
AN:
1398086
Hom.:
0
Cov.:
36
AF XY:
0.0000736
AC XY:
51
AN XY:
693014
show subpopulations
Gnomad4 AFR exome
AF:
0.000102
Gnomad4 AMR exome
AF:
0.000170
Gnomad4 ASJ exome
AF:
0.0000419
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000272
Gnomad4 FIN exome
AF:
0.0000379
Gnomad4 NFE exome
AF:
0.0000707
Gnomad4 OTH exome
AF:
0.000138
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152178
Hom.:
0
Cov.:
31
AF XY:
0.0000672
AC XY:
5
AN XY:
74420
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.0000942
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000205
Hom.:
0
Bravo
AF:
0.0000491
ExAC
AF:
0.000116
AC:
14

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 07, 2023The c.455C>A (p.P152Q) alteration is located in exon 7 (coding exon 6) of the ETV5 gene. This alteration results from a C to A substitution at nucleotide position 455, causing the proline (P) at amino acid position 152 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.35
CADD
Uncertain
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.10
T;T
Eigen
Uncertain
0.25
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.59
.;T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.22
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.7
L;L
MutationTaster
Benign
0.98
D;D;D
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-0.84
N;N
REVEL
Benign
0.097
Sift
Benign
0.097
T;T
Sift4G
Uncertain
0.049
D;D
Polyphen
0.62
P;P
Vest4
0.52
MutPred
0.34
Loss of glycosylation at P152 (P = 0.0056);Loss of glycosylation at P152 (P = 0.0056);
MVP
0.29
MPC
0.74
ClinPred
0.13
T
GERP RS
5.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.13
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs537105512; hg19: chr3-185797801; COSMIC: COSV60500242; COSMIC: COSV60500242; API